Engineering Targeted LNP Platforms for Scalable & Accessible mRNA Vaccine Development
- Exploring formulation strategies for incorporating targeting moieties into lipid nanoparticle platforms to enhance dendritic cell uptake and improve vaccine potency at lower doses
- Sharing stability optimization approaches for targeted LNP systems, including considerations around lipid degradation, storage stability, and formulation robustness during development
- Discussing how early CMC and manufacturing decisions can support scalable, cost-effective mRNA vaccine production for global access and deployment in low-resource settings